Biodesix, Inc. BDSX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -26%+5.5pp | -31.5%+9.1pp | -40.6%+3.9pp | -44.5%-0.7pp | -43.8%+4.6pp | |
| Net margin | -33.3%+6.6pp | -39.8%+9.5pp | -49.3%+4.3pp | -53.7%+0.6pp | -54.3%+5.9pp | |
| Returns | ||||||
| Return on invested capital | -45%+6.6pp | -51.6%+6.0pp | -57.6%+5.4pp | -63%+2.3pp | -65.3%+6.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1×+0.1× | 0.8×+0.1× | 0.8×-0.1× | 0.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.8×+1.0× | 1.9×0.0× | 1.8×-0.3× | 2.1×-0.1× | 2.2×-0.5× | |
| Per Share | ||||||
| Book value per share | $0.95+390% | -$0.33-42.2% | -$0.23-3,044% | $0.01-99.5% | $1.52-53.0% | |
| Valuation | ||||||
| Market capitalization | $233.52M+476% | $54.1M-10.4% | $60.4M+49.7% | $40.33M-55.8% | $91.27M-59.0% | |
| Price / sales | 2.4×+1.9× | 0.6×-0.1× | 0.8×+0.2× | 0.5×-0.7× | 1.2×-1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
